antithrombotics (Curacyte)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantithrombotics (Curacyte)
Drug Alias Namethrombin inhibitors (Curacyte)Factor XIIIa inhibitors (Curacyte)Factor Xa inhibitors (Curacyte)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIIIa inhibitorsFactor Xa inhibitorsFactor IIa inhibitors
TargetsFactor XIIIaProthrombinCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuracyte AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuracyte AG
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A